HTA SIG

Purpose

The purpose of the Healthcare Technology Assessment SIG is to provide statisticians working in the Pharmaceutical Industry engaged in Health Technology Assessments, and others in related fields of research, an opportunity to:

Collaborate and discuss strategies and methodology being applied in this area of research
Exchange information and share case studies and statistical/analytical challenges faced in HTA research
Keep abreast of new research and methodological developments
Promote and highlight opportunities for statisticians to make a positive impact in HTAs
Interact with key opinion leaders in HTA research
Organise and/or participate in workshops related to HTAs

More Information

PSI members should visit the resources section to find out more about HTA SIG meetings and membership.

Recent Activity

Latest News

Show all news

Future Events

A PSI Training Course on Improving Influence and Increasing Impact: Communication Skills for Industry Statisticians - Dates: 16 – 16 Sep, 2019

This 1-day course will lead participants, in a non-threatening and encouraging atmosphere through steps to focus on improving the key skills of making impactful verbal and written communications.

(?)
PSI Webinar: Adaptive design: updated draft FDA guidance and its implications - Dates: 04 – 04 Jul, 2019

In September 2018 the FDA published a guidance on adaptive design for clinical trials of drugs and biologics, updating (not finalizing) its initial draft from February 2010. The main focus of the webinar will be to provide an overview of its main contents, which will be presented by Jürgen Hummel (PPD). In addition, Kaspar Rufibach (Roche) will introduce an open-source statistical software for adaptive designs, RPACT (an R package that enables the design and analysis of confirmatory adaptive clinical trials). Kit Roes will also comment on the guidance from a European Regulatory perspective, which will be followed by a brief panel discussion.

(?)